These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7014685)
41. Staphylococcus aureus exfoliative toxins: how they cause disease. Plano LR J Invest Dermatol; 2004 May; 122(5):1070-7. PubMed ID: 15140205 [No Abstract] [Full Text] [Related]
43. Low density lipoprotein receptor expression on keratinocytes in normal and psoriatic epidermis. Mommaas-Kienhuis AM; Grayson S; Wijsman MC; Vermeer BJ; Elias PM J Invest Dermatol; 1987 Nov; 89(5):513-7. PubMed ID: 3668295 [TBL] [Abstract][Full Text] [Related]
44. [Demonstration by electrosyneresis of 2 exfoliation serotypes produced by Staphylococcus aureus]. Piémont Y; Monteil H Ann Microbiol (Paris); 1983; 134A(2):169-75. PubMed ID: 6870085 [TBL] [Abstract][Full Text] [Related]
45. Augmentation of staphylococcal alpha-toxin signaling by the epidermal platelet-activating factor receptor. Travers JB; Leung DY; Johnson C; Schlievert P; Marques M; Cosgrove J; Clay KL J Invest Dermatol; 2003 May; 120(5):789-94. PubMed ID: 12713583 [TBL] [Abstract][Full Text] [Related]
46. Activity requirements of epidermolytic toxin from Staphylococcus aureus studied by an in vitro assay. Smith TP; Bailey CJ Toxicon; 1990; 28(6):675-83. PubMed ID: 2119531 [TBL] [Abstract][Full Text] [Related]
48. Action of staphylococcal exfoliative toxins on epidermal cell cultures and organotypic skin. Gentilhomme E; Faure M; Piemont Y; Binder P; Thivolet J J Dermatol; 1990 Sep; 17(9):526-32. PubMed ID: 1703553 [TBL] [Abstract][Full Text] [Related]
49. Epidermal toxin production by Staphylococcus aureus strains from patients with toxic shock syndrome. Kapral FA Ann Intern Med; 1982 Jun; 96(6 Pt 2):972-4. PubMed ID: 7091978 [No Abstract] [Full Text] [Related]
50. Association between lesional or non lesional S. aureus strains from patients with impetigo and exfoliative toxin production. No association with SmaI PFGE patterns. Capoluongo E; Giglio A; Belardi M; Leonetti F; Frasca A; Giannetti A; Ameglio F New Microbiol; 2000 Jan; 23(1):21-7. PubMed ID: 10946402 [TBL] [Abstract][Full Text] [Related]
51. Action of staphylococcal alpha-toxin on membranes: some recent advances. Harshman S Mol Cell Biochem; 1979 Feb; 23(3):143-52. PubMed ID: 481427 [TBL] [Abstract][Full Text] [Related]
53. Survey of genes encoding staphylococcal enterotoxins, toxic shock syndrome toxin 1, and exfoliative toxins in members of the Staphylococcus sciuri group. Dakić I; Vukovic D; Stepanović S; Hauschild T; Jezek P; Petrás P; Morrison D J Clin Microbiol; 2005 Sep; 43(9):4875-6. PubMed ID: 16145164 [TBL] [Abstract][Full Text] [Related]
54. Staphylococcal scalded skin syndrome related to an exfoliative toxin A- and B-producing strain in preterm infants. Rieger-Fackeldey E; Plano LR; Kramer A; Schulze A Eur J Pediatr; 2002 Dec; 161(12):649-52. PubMed ID: 12447663 [TBL] [Abstract][Full Text] [Related]
55. Disruption of myelin sheaths in mouse brain in vitro and in vivo by staphylococcal alpha-toxin. Harshman S; Burt AM; Robinson JP; Blankenship M; Harshman DL Toxicon; 1985; 23(5):801-6. PubMed ID: 4089875 [TBL] [Abstract][Full Text] [Related]
57. [Isolation and purification of biologically active substances from Staphylococcus aureus isolated from a skin disease. II. Isolation and purification of exfoliative toxin]. Sugai M Hiroshima Daigaku Shigaku Zasshi; 1987 Dec; 19(2):402-8. PubMed ID: 3504874 [No Abstract] [Full Text] [Related]
58. Skin findings of Staphylococcus aureus toxin-mediated infection in relation to toxin encoding genes. Courjon J; Hubiche T; Phan A; Tristan A; Bès M; Vandenesch F; Etienne J; Del Giudice P; Gillet Y Pediatr Infect Dis J; 2013 Jul; 32(7):727-30. PubMed ID: 23446443 [TBL] [Abstract][Full Text] [Related]
59. Filatow-Dukes' disease. Epidermolytic toxin-producing staphylococci as the etiologic agent of the fourth childhood exanthem. Powell KR Am J Dis Child; 1979 Jan; 133(1):88-91. PubMed ID: 367152 [No Abstract] [Full Text] [Related]
60. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Vath GM; Earhart CA; Monie DD; Iandolo JJ; Schlievert PM; Ohlendorf DH Biochemistry; 1999 Aug; 38(32):10239-46. PubMed ID: 10441117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]